Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe

Abstract Inter-fractional tumor variance would lead to insufficient dosage or overdose in tumor region during lung cancer radiotherapy. However, previous works have not considered influence of inter-fractional tumor amplitude variance at treatment position due to lack of effective evaluation method...

Full description

Bibliographic Details
Main Authors: Yi Li, Wenjing Wu, Ruixin He, Yongkai Lu, Yuemei Zhang, Long Wang, Xiaozhi Zhang
Format: Article
Language:English
Published: Nature Portfolio 2021-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-99489-1
_version_ 1818398726476005376
author Yi Li
Wenjing Wu
Ruixin He
Yongkai Lu
Yuemei Zhang
Long Wang
Xiaozhi Zhang
author_facet Yi Li
Wenjing Wu
Ruixin He
Yongkai Lu
Yuemei Zhang
Long Wang
Xiaozhi Zhang
author_sort Yi Li
collection DOAJ
description Abstract Inter-fractional tumor variance would lead to insufficient dosage or overdose in tumor region during lung cancer radiotherapy. However, previous works have not considered influence of inter-fractional tumor amplitude variance at treatment position due to lack of effective evaluation method during radiotherapy, especially for lung tumor within the lower lobe. Our objective was to investigate inter-fractional tumor baseline shift and amplitude variance due to respiratory motion with 4DCBCT simulation and guidance during stereotactic ablative body radiotherapy (SABR) for lung tumor. Subject included 19 patients with lung tumor within the lower lobe. 4DCBCT-simulated images at treatment position were acquired sequentially to determine internal tumor volume (ITV) and reference tumor motion at simulation process. Compared with reference tumor motion, 95 4DCBCT-guided images were acquired during each treatment to evaluate inter-fractional tumor baseline shift and amplitude variance, which were − 0.0 ± 1.3 mm and − 0.2 ± 1.4 mm in left–right(LR) direction, 0.9 ± 2.3 mm and 0.4 ± 2.9 mm in superior-inferior (SI) direction, 0.1 ± 1.5 mm and − 0.4 ± 2.0 mm in anterior–posterior (AP) direction. ITV margin were 3.5 mm, 7.5 mm and 5.3 mm in LR, SI and AP directions with van Herk’s (Int J Radiat Oncol Biol Phys 52(5):1407–1422, 2002) formula. 4DCBCT simulation and guidance is a reliable method to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe. ITV margin of 3.5 mm, 7.5 mm and 5.3 mm in LR, SI and AP directions would ensure greater tumor coverage during SABR for lung tumor within the lower lobe.
first_indexed 2024-12-14T07:09:22Z
format Article
id doaj.art-0a74e161fa854e7cacddea37a0e64f73
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T07:09:22Z
publishDate 2021-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-0a74e161fa854e7cacddea37a0e64f732022-12-21T23:12:01ZengNature PortfolioScientific Reports2045-23222021-10-011111910.1038/s41598-021-99489-1Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobeYi Li0Wenjing Wu1Ruixin He2Yongkai Lu3Yuemei Zhang4Long Wang5Xiaozhi Zhang6Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiological Health, Xi’an Center for Disease Control and PreventionDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong UniversityAbstract Inter-fractional tumor variance would lead to insufficient dosage or overdose in tumor region during lung cancer radiotherapy. However, previous works have not considered influence of inter-fractional tumor amplitude variance at treatment position due to lack of effective evaluation method during radiotherapy, especially for lung tumor within the lower lobe. Our objective was to investigate inter-fractional tumor baseline shift and amplitude variance due to respiratory motion with 4DCBCT simulation and guidance during stereotactic ablative body radiotherapy (SABR) for lung tumor. Subject included 19 patients with lung tumor within the lower lobe. 4DCBCT-simulated images at treatment position were acquired sequentially to determine internal tumor volume (ITV) and reference tumor motion at simulation process. Compared with reference tumor motion, 95 4DCBCT-guided images were acquired during each treatment to evaluate inter-fractional tumor baseline shift and amplitude variance, which were − 0.0 ± 1.3 mm and − 0.2 ± 1.4 mm in left–right(LR) direction, 0.9 ± 2.3 mm and 0.4 ± 2.9 mm in superior-inferior (SI) direction, 0.1 ± 1.5 mm and − 0.4 ± 2.0 mm in anterior–posterior (AP) direction. ITV margin were 3.5 mm, 7.5 mm and 5.3 mm in LR, SI and AP directions with van Herk’s (Int J Radiat Oncol Biol Phys 52(5):1407–1422, 2002) formula. 4DCBCT simulation and guidance is a reliable method to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe. ITV margin of 3.5 mm, 7.5 mm and 5.3 mm in LR, SI and AP directions would ensure greater tumor coverage during SABR for lung tumor within the lower lobe.https://doi.org/10.1038/s41598-021-99489-1
spellingShingle Yi Li
Wenjing Wu
Ruixin He
Yongkai Lu
Yuemei Zhang
Long Wang
Xiaozhi Zhang
Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe
Scientific Reports
title Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe
title_full Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe
title_fullStr Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe
title_full_unstemmed Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe
title_short Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe
title_sort using 4dcbct simulation and guidance to evaluate inter fractional tumor variance during sabr for lung tumor within the lower lobe
url https://doi.org/10.1038/s41598-021-99489-1
work_keys_str_mv AT yili using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe
AT wenjingwu using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe
AT ruixinhe using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe
AT yongkailu using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe
AT yuemeizhang using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe
AT longwang using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe
AT xiaozhizhang using4dcbctsimulationandguidancetoevaluateinterfractionaltumorvarianceduringsabrforlungtumorwithinthelowerlobe